相关实验视频
Updated: Jan 21, 2026

13:42
RNA Secondary Structure Prediction Using High-throughput SHAPE
Published on: May 31, 2013
32.2K
使用高度特定的结构碎片预测潜在的不良药物反应
P I Savosina1, D A Filimonov1, D S Druzhilovskiy1
1Institute of Biomedical Chemistry, Moscow, Russia.
Biomeditsinskaia khimiia
|January 20, 2026
概括
在 silico 方法通过识别有害的化学结构来预测药物毒性. 这项研究发现,五种临床试验药物可能会由于潜在的表皮生长因子受体或二基酶4的抑制而带来风险.
科学领域:
- 药理学 药理学 是一个学科.
- 计算化学的计算化学
- 药物开发 药物开发
背景情况:
- 药物不良反应在药物开发中带来了重大风险和成本.
- In silico方法提供了一种方法,可以在药物发现过程的早期预测潜在的毒性.
- 识别与不良生物活性相关的特定结构动机对于风险评估至关重要.
研究的目的:
- 用预测计算方法评估临床研究的药物物质的非目标毒性.
- 为了识别与表皮生长因子受体 (EGFR) 和二乙酶4 (DPP-4) 抑制相关的特定结构碎片.
- 评估早期临床试验中候选药物的潜在益处风险比.
主要方法:
- 开发了一种方法来识别与特定不良生物活动相关的化学动机.
- 创建了EGFR和DPP-4抑制剂的高度特定的结构碎片.
- 在PubChem数据库 (12,070条目) 中搜索了在临床试验数据中含有这些片段的化合物.
主要成果:
- 在I期和II期试验中确定了五种可能具有不利的益处风险比率的化合物.
- 这些化合物显示出抑制至少一种分析的酶 (EGFR或DPP-4) 的潜力.
- 这些发现强调了与这些候选药物相关的潜在风险.
结论:
- 使用结构碎片分析进行in silico毒性评估可以在药物开发的早期确定潜在的安全问题.
- 这种方法可以帮助减轻风险,减少与药物开发相关的财务和时间成本.
- 整合这些分析框架有助于推出更安全,更具成本效益的治疗药物.
相关概念视频
Predicting Reaction Outcomes
10.3K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.3K
Sensitivity, Specificity, and Predicted Value
1.2K
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
1.2K
Allergic Drug Reactions
1.4K
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.4K
Habitat Fragmentation
21.2K
Habitat fragmentation describes the division of a more extensive, continuous habitat into smaller, discontinuous areas. Human activities such as land conversion, as well as slower geological processes leading to changes in the physical environment, are the two leading causes of habitat fragmentation. The fragmentation process typically follows the same steps: perforation, dissection, fragmentation, shrinkage, and attrition.
21.2K
Drug Metabolism: Phase I Reactions
4.6K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.6K
Drug Metabolism: Phase II Reactions
4.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.9K

